Patent ID: 9274120
Filing Date: 2016-03-01
CPC Classification: A61P,C12Q,G01N

Claim Text:
1. A method of treating a carcinoma of the pancreas or ovarian cancer in a patient, said method comprising the following steps: (a) determining whether said patient is susceptible to treatment with a protein tyrosine kinase 2 (PTK2) inhibitor by detecting the amount of expression of the E-cadherin protein in a cancer sample taken from said patient, wherein an E-cadherin protein immunoreactivity score (IRS) of 0 indicates that the patient is susceptible to treatment with a PTK2 inhibitor; and (b) treating said patient with a protein tyrosine kinase 2 (PTK2) inhibitor if it has been determined that said patient is susceptible to treatment with a protein tyrosine kinase 2 (PTK2) inhibitor.